Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christa Liesche Borgman, M.D.

Concepts (104)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HSP90 Heat-Shock Proteins320124350.170 Why?
Lung Neoplasms92012129850.140 Why?
HSP27 Heat-Shock Proteins12012610.110 Why?
Quinazolines2200913560.100 Why?
Carcinoma, Non-Small-Cell Lung5201251540.100 Why?
Mammary Neoplasms, Experimental120125220.090 Why?
Carcinoma, Adenosquamous12009680.080 Why?
Dideoxynucleosides120081240.080 Why?
Receptor, erbB-22200923700.080 Why?
Down-Regulation2201229990.070 Why?
Bronchial Neoplasms120071120.070 Why?
Triazoles120129060.070 Why?
Genes, erbB-2120071620.070 Why?
Quinolines220077210.060 Why?
Sirolimus2200915590.060 Why?
Cell Line, Tumor82012166460.060 Why?
Neoplasm Metastasis2201048320.050 Why?
Oncogene Proteins, Fusion1201015740.050 Why?
Pyrroles1200911420.050 Why?
Xenograft Model Antitumor Assays4201235620.050 Why?
Adenocarcinoma2201063180.050 Why?
Mutation52009296580.050 Why?
Enzyme Inhibitors2201038020.050 Why?
Indoles1200918320.050 Why?
Antineoplastic Agents42012136350.040 Why?
Gene Expression Regulation, Neoplastic3201284000.040 Why?
Angiogenesis Inhibitors1200920370.040 Why?
Pyrimidines1201029180.040 Why?
Antineoplastic Combined Chemotherapy Protocols22009114100.040 Why?
Proteomics1201035840.040 Why?
Drug Resistance, Neoplasm2200951480.040 Why?
In Situ Nick-End Labeling220086410.040 Why?
Mice, SCID2201227160.040 Why?
AMP-Activated Protein Kinases220106070.030 Why?
Protein Kinase Inhibitors2201055020.030 Why?
Mice92012810020.030 Why?
Signal Transduction42010233550.030 Why?
Genomics1201056520.030 Why?
Blotting, Western2201251810.030 Why?
Positron-Emission Tomography1200863610.030 Why?
Reverse Transcriptase Polymerase Chain Reaction2201247430.030 Why?
Intramolecular Oxidoreductases120121090.030 Why?
Proto-Oncogene Proteins p21(ras)2201016740.030 Why?
Vascular Endothelial Growth Factor C120121270.030 Why?
Benzoquinones120122010.030 Why?
Protein-Tyrosine Kinases2201024550.020 Why?
Gene Expression Profiling3201293870.020 Why?
Lactams, Macrocyclic120123200.020 Why?
Protein Stability120125540.020 Why?
Immunohistochemistry32009113470.020 Why?
MAP Kinase Kinase 212010970.020 Why?
Neovascularization, Pathologic2201226390.020 Why?
TOR Serine-Threonine Kinases2201021020.020 Why?
Fibroblast Growth Factor 2120126000.020 Why?
Focal Adhesions120101210.020 Why?
Focal Adhesion Protein-Tyrosine Kinases120101830.020 Why?
Cell Transdifferentiation120101700.020 Why?
Animals920121683680.020 Why?
MAP Kinase Kinase 1120103380.020 Why?
Phosphorylation2201084160.020 Why?
Mitogen-Activated Protein Kinase Kinases120106480.020 Why?
src-Family Kinases120105490.020 Why?
Carboplatin120108000.020 Why?
Mice, Mutant Strains1201018830.020 Why?
Ki-67 Antigen120086420.020 Why?
ras Proteins1201010620.020 Why?
Breast Neoplasms12012206760.020 Why?
Tumor Burden1201019040.020 Why?
Transplantation, Heterologous1201223810.010 Why?
Mice, Nude1201036920.010 Why?
Cell Adhesion1201031370.010 Why?
Cluster Analysis1201027110.010 Why?
Oligonucleotide Array Sequence Analysis1201239220.010 Why?
Drug Evaluation, Preclinical1200913740.010 Why?
Paclitaxel1201017010.010 Why?
Genetic Engineering120099550.010 Why?
Receptor Protein-Tyrosine Kinases1201016590.010 Why?
Gene Amplification1200710610.010 Why?
RNA Interference1201028990.010 Why?
Protein Kinases1200816370.010 Why?
Vascular Endothelial Growth Factor A1201235040.010 Why?
Up-Regulation1201042050.010 Why?
Phosphatidylinositol 3-Kinases1201029330.010 Why?
Cell Cycle1200829600.010 Why?
Protein Binding1201293750.010 Why?
Drug Therapy, Combination1201064780.010 Why?
Intracellular Signaling Peptides and Proteins1201029010.010 Why?
Amino Acid Sequence12010138160.010 Why?
Cell Movement1201052210.010 Why?
Mice, Transgenic1201097340.010 Why?
Proto-Oncogene Proteins1201045550.010 Why?
Survival Analysis12010102470.010 Why?
Molecular Sequence Data12010181250.010 Why?
Cell Transformation, Neoplastic1200729360.010 Why?
Cell Proliferation12012104550.010 Why?
Cells, Cultured12012192200.010 Why?
Early Detection of Cancer1200830510.010 Why?
Female420123788530.010 Why?
Apoptosis1200897140.010 Why?
Humans620127393980.010 Why?
Time Factors12012400500.010 Why?
Disease Models, Animal12009180030.010 Why?
Male220123490220.000 Why?
Treatment Outcome12008626930.000 Why?
Borgman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (104)
Explore
_
Co-Authors (15)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.